Content specific to this active ingredient… Drug Information Prescribing and patient information from leading authorities Drug Master Files Type 2 master files on file at the FDA Drug Recalls For prescription drugs containing this active ingredient Exclusivity Patent and market exclusivity data Federal Register FR search results for this API FDA Approved Labelling Information found in this drug's package inserts Research Links Chemical identification and research citations Title 21 Code of Federal Regulations FDA regulations for this API

FDA Approval Activities for this Drug… DISOPYRAMIDE PHOSPHATE Capsule, Extended Release; 100MG BASE NORPACE CR GD SEARLE 018655 DISOPYRAMIDE PHOSPHATE Capsule, Extended Release; 150MG BASE NORPACE CR GD SEARLE 071200 DISOPYRAMIDE PHOSPHATE Capsule, Extended Release; 150MG BASE DISOPYRAMIDE PHOSPHATE KV 017447 DISOPYRAMIDE PHOSPHATE Capsule; 100MG BASE NORPACE GD SEARLE 017447 DISOPYRAMIDE PHOSPHATE Capsule; 150MG BASE NORPACE GD SEARLE 070470 DISOPYRAMIDE PHOSPHATE Capsule; 100MG BASE DISOPYRAMIDE PHOSPHATE Geneva 070471 DISOPYRAMIDE PHOSPHATE Capsule; 150MG BASE DISOPYRAMIDE PHOSPHATE Geneva 070186 DISOPYRAMIDE PHOSPHATE Capsule; 100MG BASE DISOPYRAMIDE PHOSPHATE Ivax 070187 DISOPYRAMIDE PHOSPHATE Capsule; 150MG BASE DISOPYRAMIDE PHOSPHATE Ivax 070940 DISOPYRAMIDE PHOSPHATE Capsule; 100MG BASE DISOPYRAMIDE PHOSPHATE SUPERPHARM 070101 DISOPYRAMIDE PHOSPHATE Capsule; 100MG BASE DISOPYRAMIDE PHOSPHATE Teva 070102 DISOPYRAMIDE PHOSPHATE Capsule; 150MG BASE DISOPYRAMIDE PHOSPHATE Teva 070173 DISOPYRAMIDE PHOSPHATE Capsule; 100MG BASE DISOPYRAMIDE PHOSPHATE Watson 070174 DISOPYRAMIDE PHOSPHATE Capsule; 150MG BASE DISOPYRAMIDE PHOSPHATE Watson | Disopyramide Phosphate Capsules, Teva Pharma, Control Suppl. ^ FDA's latest approval appears at the bottom of this list. ^   A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U-Z Health Topics | News Feed for each API | DMF Index | Pharma Job Search | Pharma Company News © 2008 Betterchem.com